| For: | Ahmed F, Zakaria F, Enebong Nya G, Mouchli M. Sirolimus vs tacrolimus: Which one is the best therapeutic option for patients undergoing liver transplantation for hepatocellular carcinoma? World J Gastrointest Surg 2022; 14(8): 862-866 [PMID: 36157369 DOI: 10.4240/wjgs.v14.i8.862] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v14/i8/862.htm |
| Number | Citing Articles |
| 1 |
Mohamed E. Nady, Ola M. Abd El-Raouf, El-Sayed M. El-Sayed. Linagliptin ameliorates tacrolimus-induced renal injury: role of Nrf2/HO-1 and HIF-1α/CTGF/PAI-1. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09533-2
|
| 2 |
Satoshi Asanuma, Koichiro Haruki, Kenei Furukawa, Shinji Onda, Yoshihiro Shirai, Michinori Matsumoto, Tomohiko Taniai, Masashi Tsunematsu, Mitsuru Yanagaki, Toru Ikegami. Incidental intrahepatic cholangiocarcinoma detected in the explant liver after living-donor liver transplantation for polycystic liver disease. Clinical Journal of Gastroenterology 2026; doi: 10.1007/s12328-026-02343-y
|
| 3 |
Cristina Baciu, Bima J. Hasjim, Saba Maleki, Elisa Pasini, Meera Kennedybhai Patel, Maryam Shojaee, Amirhossein Azhie, Giovanna Saracino, Sumeet K. Asrani, Mamatha Bhat. Metabolomics Analysis Uncovers Distinct Profiles of Liver Post-Transplant Patients by Immunosuppression Regimen. Metabolites 2025; 15(11): 700 doi: 10.3390/metabo15110700
|